Successful use of dexmedetomidine for sedation in a 24-week gestational age neonate

Annals of Pharmacotherapy

Volumn 43, Issue 10, 2009, Pages 1707-1713

  O'Mara, Keliana ^a   Gal, Peter ^a,b,c   Ransom, J Laurence ^a   Wimmer Jr , John E ^a,d   Carlos, Rita Q ^a   Dimaguila, Mary Ann V T ^a   Davonzo, Christie ^a   Smith, McCrae ^a  

^a The Women's Hospital of Greensboro   (United States)

^b Graduate Pharmacy Education   (United States)

^c University of North Carolina at Chapel Hill   (United States)

^d Women's Hospital of Greensboro ^*

Author keywords

Dexmedetomidine; Premature neonate; Sedation

Indexed keywords

BENZODIAZEPINE DERIVATIVE; DEXAMETHASONE; DEXMEDETOMIDINE; DOBUTAMINE; DOPAMINE; FENTANYL; HYDROCORTISONE; LORAZEPAM; LUNG SURFACTANT; MIDAZOLAM; NARCOTIC AGENT; PHENOBARBITAL;

ABSENCE OF SIDE EFFECTS; ADD ON THERAPY; AGITATION; ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; CONTINUOUS INFUSION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG MEGADOSE; DRUG USE; EXTUBATION; HUMAN; HYPOTENSION; INFUSION RATE; LOADING DRUG DOSE; MALE; NEWBORN; OXYGEN SATURATION; PREMATURITY; PRIORITY JOURNAL; SEDATION; SINGLE DRUG DOSE;

DEXMEDETOMIDINE; HUMANS; HYPNOTICS AND SEDATIVES; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; MALE; PSYCHOMOTOR AGITATION; RESPIRATION, ARTIFICIAL; TREATMENT OUTCOME;

EID: 70449500266     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1M245     Document Type: Article

References (48)

1. Tobias JD, Berkenbasch J. Sedation during mechanical ventilation in infants and children: dexmedetomidine versus midazolam. South Med J 2004;97:451-455 DOI 10.1097/00007611-200405000-00007
2. Barton KP, Munoz R, Morell VO, Chrysostomou C. Dexmedetomidine as the primary sedative during invasive procedures in infants and toddlers with congenital heart disease. Pediatr Crit Care Med 2008;9:612-615 DOI 10.1097/PCC.0b013e31818d320d
3. Walker J, Maccallum M, Fischer C, Kopcha R, Saylors R, McCall J. Sedation using dexmedetomidine in pediatric burn patients. J Burn Care Res 2006;27:206-210 DOI 10.1097/01.BCR.0000200910.76019.CF (Pubitemid 43970324)
4. Lubisch N, Roskos R, Sattler SM. Improving outcomes in pediatric procedural sedation. Jt Comm J Qual Saf 2008;34:192-195
5. Zub D, Berkenbosch JW, Tobias JD. Preliminary experience with oral dexmedetomidine for procedural and anesthetic premedication. Paediatr Anaesth 2005;15:932-938 DOI 10.1111/j.1460-9592.2005.01623.x
6. Tobias JD. Subcutaneous dexmedetomidine infusions to treat or prevent drug withdrawal in infants and children. J Opioid Manag 2008;4:187-191
7. Finkel JC, Johnson YJ, Quezado ZM. The use of dexmedetomidine to facilitate acute discontinuation of opioids after cardiac transplantation in children. Crit Care Med 2005;33:2110-2112 DOI 10.1097/01.CCM.0000178183.21883.23
8. Munro HM, Tirotta CF, Felix DE, et al. Initial experience with dexmedetomidine for diagnostic and interventional cardiac catheterization in children. Paediatr Anaesth 2007;17:109-112 DOI 10.1111/j.1460-9592.2006.02031.x
9. Mason KP, Zurakowski D, Zgleszewski SE, et al. High dose dexmedetomidine as the sole sedative for pediatric MRI. Paediatr Anaesth 2008;18: 403-411 DOI 10.1111/j.1460-9592.2008.02468.x
10. Ibacache ME, Munoz HR, Brandes V, Morales AL. Single-dose dexmedetomidine reduces agitation after sevoflurane anesthesia in children. Anesth Analg 2004;98:60-63 DOI 10.1213/01.ANE.0000094947.20838.8E (Pubitemid 38029843)
11. Isik B, Arslan M, Tunga AD, Kurtipek O. Dexmedetomidine decreases emergence agitation in pediatric patients after sevoflurane anesthesia without surgery. Paediatr Anaesth 2006;16:748-753 DOI 10.1111/J.1460-9592.2006.01845.X (Pubitemid 44365964)
12. Khasawinah TA, Ramirez A, Berkenbosch JW, Tobias JD. Preliminary experience with dexmedetomidine in the treatment of cyclic vomiting syndrome. Am J Ther 2003;10:303-307 DOI 10.1097/00045391-200307000-00012
13. Venn RM, Hell J, Grounds RM. Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Crit Care 2000;4:302-308 Epub 31 Jul 2000. DOI 10.1186/cc712
14. Memis D, Dokmeci D, Karamanlioglu B, Turan A, Ture M. A comparison of the effect on gastric emptying of propofol or dexmedetomidine in critically ill patients: preliminary study. Eur J Anaesthesiol 2006;23:700-704 DOI 10.1017/S0265021506000512
15. Ma D, Hossain M, Rajakumaraswamy N, et al. Dexmedetomidine produces neuroprotective effects via the a2A-receptor subtype. Eur J Pharmacol 2004;502:87-97.
16. Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006;3:CD004454. DOI 10.1002/14651858.CD004454.pub2
17. Soraisham AS, Singhal N, McMillan DD, Sauve RS, Lee SK, Canadian Neonatal Network. A multicenter study on the clinical outcome of chorioamnionitis in preterm infants. Am J Obstet Gynecol 2009;200: 372e1-372e6. Epub 14 Feb 2009 (accessed 2009 Jan 26). DOI 10.1016/j.ajog.2008.11.034
18. Taddio A, Shah V, Atenafu E, Katz J. Influence of repeated painful procedures and sucrose analgesia on the development of hyperalgesia in newborn infants. Pain 2009;144:43-48 Epub 28 Mar 2009. DOI 10.1016/j.pain.2009.02.012
19. Ng PC. Is there a "normal" range of serum cortisol concentrations for preterm infants? Pediatr 2008;122:873-875 DOI 10.1542/peds.2008-0516
20. Odd DE, Armstrong DL, Teele RL, Kuschel CA, Harding JE. A randomized trial of two dexamethasone regimens to reduce side-effects in infants treated for chronic lung disease of prematurity. J Paediatr Child Health 2004;40:282-289 DOI 10.1080/14767050500363519
21. McCrea H, Ment L. The diagnosis, management, and postnatal prevention of intraventricular hemorrhage in the preterm neonate. Clin Perinatol 2008;35:777-792 DOI 10.1016/j.clp.2008.07.014
22. Bekkali N, Hamers SL, Schipperus MR, et al. Duration of meconium passage in preterm and term infants. Arch Dis Child Fetal Neonatal Ed 2008;93:F376-9. Epub 19 Feb 2008. DOI 10.1136/adc.2008.138024
23. Greenholz SK, Perez C, Wesley JR, Marr CC. Meconium obstruction in markedly premature infant. J Pediatr Surg 1996;31:117-122 DOI 10.1016/S0022-3468(96)90332-22
24. Simmons S, Anand K. Pain control: opioid dosing, population kinetics, and side effects. Semin Fetal Neonatal Med 2006;11:260-267 Epub 18 Apr 2006. DOI 10.1016/j.siny.2006.02.008 (Pubitemid 43794844)
25. Richman PS, Baram D, Varela M, Glass PS. Sedation during mechanical ventilation: a trial of benzodiazepine and opiate in combination. Crit Care Med 2006;34:e1395- 401. Epub 14 Apr 2008 (accessed 2009 Jan 26). DOI 10.1097/01.CCM.0000215454.50964.F8
26. Darnell CM, Thompson J, Stromberg D, Roy L, Sheeran P. Effect of low-dose naloxone infusion on fentanyl requirements in critically ill children. Pediatr 2008;121:1363-1371 DOI 10.1542/peds.2007-1468
27. Lam S, Alexander E. Dexmedetomidine use in critical care. AACN Adv Crit Care 2008;19:113-120 DOI 10.1097/01.AACN.0000318109.06073.35
28. Bejian S, Valasek C, Nigro J, Cleveland D, Willis B. Prolonged use of dexmedetomidine in the paediatric cardiothoracic intensive care unit. Cardiol Young 2009;19:98-104. Epub 20 Jan 2009. DOI 10.1017/S1047951109003515
29. Riker R, Shehabi Y, Bokesch P, et al. Dexmedetomidine versus midazolam for sedation of critically ill patients. JAMA 2009;301:489-499 Epub 2 Feb 2009. DOI 10.1001/jama.2009.56
30. Reiter PD, Pietras M, Dobyns EL. Prolonged dexmedetomidine infusions in critically ill infants and children. Indian Pediatr. Epub 1 Apr 2009 (accessed 2009 May 20).
31. Dominguez KD, Lomako DM, Katz RW, Kelly HW. Opioid withdrawal in critically ill neonates. Ann Pharmacother 2003;37:473-477 Epub 28 Feb 2003. DOI 10.1345/aph.1C324
32. Enomoto Y, Kudo T, Saito T, et al. Prolonged use of dexmedetomidine in an infant with respiratory failure following living liver donor transplantation. Paediatr Anaesth 2006;16:1285-1288 DOI 10.1111/j.1460-9592.2006.02008.x (Pubitemid 44760224)
33. Hsu Y-W, Cortinez LI, Robertson KM, et al. Dexmedetomidine pharmacodynamics: part I: crossover comparison of respiratory effects of dexmedetomidine and remifentanil in healthy volunteers. Anesth 2004; 101:1066-1076 DOI 10.1097/00000542-200411000-00005
34. Bhana N, Goa KL, McClellan KJ. Dexmedetomidine. Drugs 2000;59: 263-268 DOI 10.2165/00003495-200059020-00012
35. Potts A, Warman G, Anderson B. Dexmedetomidine disposition in children: a population analysis. Pediatr Anesth 2008;18:722-730 DOI 10.1111/j.1460-9592. 2008.02653.x (Pubitemid 352000581)
36. Vilo S, Rautiainen P, Kaisti K, et al. Pharmacokinetics of intravenous dexmedetomidine in children under 11 yr of age. Br J Anaesth 2008;100: 697-700. DOI 10.1093/bja/aen070 (Pubitemid 351774374)
37. Cosar M, Eser O, Fidan H, et al. The neuroprotective effect of dexmedetomidine in the hippocampus of rabbits after subarachnoid hemorrhage. Surg Neurol 2009;71:54-59 Epub 22 Jan 2008. DOI 10.1016/j.surneu.2007.08.020
38. Eser O, Fidan H, Sahin O, et al. The influence of dexmedetomidine on ischemic rat hippocampus. Brain Res 2008;1218:250-256 Epub 27 Apr 2008. DOI 10.1016/j.brainres.2008.04.045
39. Kuhmonen J, Pokorny J, Miettinen R, et al. Neuroprotective effects of dexmedetomidine in the gerbil hippocampus after transient global ischemia. Anesthesiology 1997;87:371-377 (Pubitemid 27435380)
40. Mellon RD, Simone AF, Rappaport B. Use of anesthetic agents in neonates and young children. Anesth Analg 2007;104:509-520 DOI 10.1213/01.ane.0000255729. 96438.b0 (Pubitemid 46309863)
41. Anand KJ, Hall RW, Desai N, et al. Effects of morphine analgesia in ventilated preterm neonates: primary outcomes from the NEOPAIN randomized trial. Lancet 2004;263:1673-1682 DOI 10.1016/S0140-6736(04)16251-X (Pubitemid 38670324)
42. Rao R, Sampers JS, Kronsberg SS, Brown JV, Desai NS, Anand KJ. Neurobehavior of preterm infants at 36 weeks postconception as a function of morphine analgesia. Am J Perinatol 2007;24:511-517 DOI 10.1055/s-2007-986675 (Pubitemid 47623680)
43. Maze M, Virtanen R, Daunt D, Banks SJ, Stover EP, Feldman D. Effects of dexmedetomidine, a novel imidazole sedative - anesthetic agent, on adrenal steroidogenesis: in vivo and vitro studies. Anesth Analg 1991; 73:204-208 DOI 10.1213/00000539-199108000-00015
44. Czaja A, Zimmerman J. The use of dexmedetomidine in critically ill children. Pediatr Crit Care Med 2009;10:381-386 DOI 10.1097/PCC.0b013e3181a3191f
45. Carroll CL, Krieger D, Campbell M, Fisher DG, Comeau LL, Zucker AR. Use of dexmedetomidine for sedation of children hospitalized in the intensive care unit. J Hosp Med 2008;3:142-147 DOI 10.1002/jhm.282 (Pubitemid 351722126)
46. Watterberg K, Gerdes JS, Gifford KL, Lin HM. Prophylaxis against early adrenal insufficiency to prevent chronic lung disease in premature infants. Pediatrics 1999;104:1258-1263 DOI 10.1542/peds.104.6.1258
47. Watterberg KL, Scott SM, Backstrom C, Gifford KL, Cook KL. Links between early adrenal insufficiency and respiratory outcome in preterm infants: airway inflammation and patent ductus arteriosus. Pediatrics 2000;105:320-324 DOI 10.1542/peds.105.2.320 (Pubitemid 30078671)
48. Watterberg KL, Gerdes JS, Cole CH, et al. Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial. Pediatrics 2004;114:1649-1657 DOI 10.1542/peds.2004-11